Susquehanna International Group
ORKA

Susquehanna International Group’s Oruka Therapeutics ORKA Stock Holding History

Susquehanna International Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Buy
20,984
+12,319
+142% +$428K ﹤0.01% 7816
2025
Q4 		$263K Buy
+8,665
New +$241K ﹤0.01% 10268
2025
Q3 		– Sell
-33,962
Closed -$503K – 14192
2025
Q2 		$381K Sell
33,962
-316,074
-90% -$3.29M ﹤0.01% 9811
2025
Q1 		$3.59M Buy
+350,036
New +$4.37M ﹤0.01% 4299
2022
Q4 		– Sell
-26,184
Closed -$671K – 13897
2022
Q3 		$647K Buy
26,184
+7,191
+38% +$203K ﹤0.01% 7764
2022
Q2 		$568K Buy
+18,993
New +$537K ﹤0.01% 7949
2022
Q1 		– Sell
-2,672
Closed -$66.2K – 14137
2021
Q4 		$69K Sell
2,672
-6,498
-71% -$196K ﹤0.01% 12394
2021
Q3 		$326K Buy
9,170
+691
+8% +$25.5K ﹤0.01% 10417
2021
Q2 		$355K Sell
8,479
-405
-5% -$16.9K ﹤0.01% 10408
2021
Q1 		$389K Buy
8,884
+6,197
+231% +$325K ﹤0.01% 10045
2020
Q4 		$129K Buy
+2,687
New +$134K ﹤0.01% 10355
2019
Q2 		– Sell
-337
Closed -$27K – 10946
2019
Q1 		$27K Buy
+337
New +$29.9K ﹤0.01% 8560
2018
Q3 		– Sell
-221
Closed -$26K – 10404
2018
Q2 		$26K Buy
+221
New +$25.9K ﹤0.01% 9396
2018
Q1 		– Sell
-48
Closed -$14K – 10329
2017
Q4 		$14K Buy
+48
New +$13.9K ﹤0.01% 9104
2015
Q3 		– Sell
-376
Closed -$653K – 10303
2015
Q2 		$653K Buy
+376
New +$494K ﹤0.01% 7095

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Susquehanna International Group's ORKA Position: Q1 2026 in Review

Susquehanna International Group increased its Oruka Therapeutics (ORKA) stake by 142% in Q1 2026, buying an estimated $428K and bringing the position to 20,984 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #7816.

Susquehanna International Group first reported a position in ORKA in Q2 2015 and has held it in 15 quarters since. The position peaked at $3.59M in Q1 2025. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Susquehanna International Group held 20,984 shares of Oruka Therapeutics worth $1.03M as of Q1 2026.
  • Susquehanna International Group bought 12,319 Oruka Therapeutics shares in Q1 2026, an estimated $428K.
  • Oruka Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7816 holding.
  • Susquehanna International Group first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 15 quarters since.
  • Susquehanna International Group's Oruka Therapeutics position peaked at $3.59M in Q1 2025.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.